How Can Service Teams Quantify Carryover Risk in a Repetitive Immunoassay Workflow?

Technical comparison / troubleshooting is one of the most commercially useful content types for Due Bio because buyers, distributors, and OEM partners often search in question form before they start a formal sourcing conversation. Key Takeaway Carryover risk should be quantified with high-to-low sequencing, residual signal thresholds, wash verification, and repeatability limits before blaming calibrators. … Read more

POCT What Should IVD Distributors Ask Before Choosing a CRISPR POCT OEM Partner?

IVD distributors choosing a CRISPR POCT OEM partner should evaluate more than whether the supplier can provide Cas12 or Cas13 chemistry. The real question is whether the partner can support a complete commercialization path: sample workflow, amplification compatibility, lateral flow or fluorescence readout, validation documentation, packaging, shelf-life, and OEM/ODM execution. Key Takeaway Before choosing a … Read more

POCT: How Should IVD Distributors Evaluate Nucleic Acid Release Reagents for Rapid Sample Preparation?

Nucleic acid release reagents are sample preparation reagents designed to lyse cells, viruses, or other biological materials and make DNA or RNA available for downstream amplification without a full extraction workflow. For IVD distributors, the key question is not whether a release reagent works in theory, but whether it works reliably with the intended sample … Read more